title: Dual-function of thiocyanate on nitrite-induced formation of reactive nitrogen oxide species in human oral cavity: inhibition under neutral and enhancement under acidic conditions.
abstract: Salivary nitrate is reduced to nitric oxide (NO) via nitrite in the human oral cavity. The nitrite and NO formed can be transformed to reactive nitrogen oxide species (RNOS). In this investigation, RNOS formed in mixed whole saliva and its fractions were detected by the oxidation of aminophenyl fluorescein (APF) and the transformation of 3-amino-4-monomethylamino-2',7'-difluorofluorecein (DAF-FM) to its triazol form (DAF-FMT). Nitrite-induced oxidation of APF and formation of DAF-FMT increased as pH was decreased from 7 to 5 and SCN- inhibited the oxidation of APF and the formation of DAF-FMT around neutral pH and enhanced at pH about 5. The SCN- -dependent inhibition was due to the suppression of salivary peroxidase and the enhancement was due to the formation of NOSCN from HNO2 and SCN-. It is deduced that the increase in the concentrations of nitrite and H+ in the oral cavity may result in the enhanced formation of
authors.affiliation: Department of Bioscience, Kyushu Dental College, Kitakyushu 803-8580, Japan. takahama@kyu-dent.ac.jp
authors.forename: Umeo
authors.initials: U
authors.lastname: Takahama
authors.forename: Kanako
authors.initials: K
authors.lastname: Ryu
authors.forename: Takayuki
authors.initials: T
authors.lastname: Oniki
authors.forename: Sachiko
authors.initials: S
authors.lastname: Hirota
mesh_terms: D000143:Acids / Q000494:pharmacology*; D000814:Aniline Compounds / Q000493:pharmacokinetics; D001419:Bacteria / Q000187:drug effects; D002245:Carbon Dioxide / Q000494:pharmacology; D005021:Ethylamines / Q000737:chemistry / Q000378:metabolism; D005452:Fluoresceins / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008954:Models, Biological; D009055:Mouth / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology; D009569:Nitric Oxide / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology*; D009574:Nitro Compounds / Q000494:pharmacology; D010084:Oxidation-Reduction; D004369:Pentetic Acid / Q000494:pharmacology; D009195:Peroxidase / Q000378:metabolism; D011794:Quercetin / Q000494:pharmacology; D026361:Reactive Nitrogen Species / Q000378:metabolism*; D012463:Saliva / Q000737:chemistry / Q000378:metabolism / Q000382:microbiology; D013861:Thiocyanates / Q000037:antagonists & inhibitors* / Q000494:pharmacology*
chemical_list: C527813:3-amino-4-monomethylamino-2',7'-difluorofluorecein; D000143:Acids; D000814:Aniline Compounds; D005021:Ethylamines; D005452:Fluoresceins; D009573:Nitrites; D009574:Nitro Compounds; D026361:Reactive Nitrogen Species; D013861:Thiocyanates; C508569:aminophenyl fluorescein; D002245:Carbon Dioxide; D009569:Nitric Oxide; D004369:Pentetic Acid; C061872:FK 409; D011794:Quercetin; D009195:Peroxidase; C031760:thiocyanate